- Home
- INBX vs IIF Comparison
INBX vs IIF Comparison
Compare INBX & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- IIF
- Stock Information
- Founded
- INBX 2010
- IIF 1993
- Country
- INBX United States
- IIF United States
- Employees
- INBX N/A
- IIF N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- IIF Trusts Except Educational Religious and Charitable
- Sector
- INBX Health Care
- IIF Finance
- Exchange
- INBX Nasdaq
- IIF Nasdaq
- Market Cap
- INBX 198.2M
- IIF 230.8M
- IPO Year
- INBX 2020
- IIF N/A
- Fundamental
- Price
- INBX $14.05
- IIF $24.01
- Analyst Decision
- INBX Hold
- IIF
- Analyst Count
- INBX 1
- IIF 0
- Target Price
- INBX N/A
- IIF N/A
- AVG Volume (30 Days)
- INBX 100.7K
- IIF 45.4K
- Earning Date
- INBX 05-08-2025
- IIF 01-01-0001
- Dividend Yield
- INBX 6.06%
- IIF 13.94%
- EPS Growth
- INBX N/A
- IIF N/A
- EPS
- INBX 112.62
- IIF N/A
- Revenue
- INBX $200,000.00
- IIF N/A
- Revenue This Year
- INBX N/A
- IIF N/A
- Revenue Next Year
- INBX N/A
- IIF N/A
- P/E Ratio
- INBX $0.12
- IIF N/A
- Revenue Growth
- INBX N/A
- IIF N/A
- 52 Week Low
- INBX $10.80
- IIF $18.95
- 52 Week High
- INBX $18.95
- IIF $24.41
- Technical
- Relative Strength Index (RSI)
- INBX 52.88
- IIF 50.25
- Support Level
- INBX $13.51
- IIF $24.21
- Resistance Level
- INBX $14.64
- IIF $24.59
- Average True Range (ATR)
- INBX 0.74
- IIF 0.34
- MACD
- INBX -0.03
- IIF 0.08
- Stochastic Oscillator
- INBX 45.85
- IIF 55.05
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.